key: cord-1011578-30fi614e authors: Moniri, Afshin; Marjani, Majid; Tabarsi, Payam; Yadegarynia, Davood; Nadji, Seyed Alireza title: Health Care Associated Middle East Respiratory Syndrome (MERS): A Case from Iran date: 2015 journal: Tanaffos DOI: nan sha: 38961185beb38aa928232a73801aa76944468e07 doc_id: 1011578 cord_uid: 30fi614e Middle East respiratory syndrome coronavirus (MERS-CoV) Infection, has caused recurrent outbreaks worldwide. It is associated with severe morbidity and mortality, and is not treatable with the currently available antiviral therapies. We present a case of a 43 year-old male healthcare provider, who admitted with productive cough, dyspnea, myalgia, pleuritic chest pain and fever. Computed tomography (CT) showed bilateral ground glass opacities and consolidation. Sputum polymerase chain reaction (PCR) for MERS-coronavirus was positive. Middle East respiratory syndrome coronavirus (MERS-CoV) Infection, has caused recurrent outbreaks worldwide. It is associated with severe morbidity and mortality, and is not treatable with the currently available antiviral therapies (1) . Since its emergence in 2012, about 1595 laboratory-confirmed cases of MERS have been reported with a fatality rate of more than 30% (global deaths 571) (2) . variable, ranging from asymptomatic to very severe pneumonia with acute respiratory distress syndrome, septic shock and multi-organ failure resulting in death. There is growing evidence that dromedary camel is a reservoir for the virus and a source of human infection (3) . Although it is likely that zoonotic transmission is the starting point of most clusters, person-to-person transmission is the most common form of transmission for MERS-CoV. Nosocomial transmission amplified the spread of MERS, and the majority of cases so far have been reported from hospital outbreaks in Saudi Arabia, the United Arab Emirates and South Korea (4 A 43 year-old male anesthesiologist who was also a cigarette smoker from Kerman province of Iran presented with productive cough, dyspnea, myalgia, pleuritic chest pain and fever since 10 days prior to admission on June 16, He was well up until 14 days prior to admission. He gave a history of intubating a patient in an emergency situation without standard protective measures. The intubated patient was later diagnosed with MERS-CoV. Four days later, he developed dyspnea, fever, myalgia, pleuritic chest pain and cough (first dry and then became productive). The patient was referred to Dr. Masih Daneshvari Hospital -NRITLD in Tehran. Upon admission, the patient's body temperature was 38.1°C, blood pressure was 95/50 mmHg, pulse rate was 106 beats/min, respiratory rate was 32/min and percutaneous oxygen saturation was 63% in room air. Pulmonary An analysis showed that 59% of cases were secondary cases with an epidemiologic relation to other confirmed cases and infection in these cases has occurred more frequently in healthcare settings (63.2%) than due to family contacts (13.7%) (18) . In a recent update by the WHO, it was noted that the number of laboratory-confirmed MERS-CoV cases increased sharply in relation to the occurrence of health-care-associated outbreaks (6). Saudi Arabia and three patterns of transmission were described (sporadic, within families, nosocomial transmission to healthcare workers). The true incidence of the disease in the community is not known. Of the 1,695 healthcare contacts and 462 family contacts of confirmed MERS cases, a positive result was obtained from 19 (1.12%) healthcare workers and 14 (3.6%) cases of family contacts. As a result, the rate of secondary transmission among family contact is higher than other contacts (19) . Thus, Infection in the healthcare setting is an important risk factor for human-to-human transmission and close and prolonged contact with the index case seems to be a necessity for the disease transmission (20) . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia Middle East respiratory syndrome coronavirus (MERS-CoV) -Saudi Arabia European Centre for Disease Prevention and Control. Factsheet for health professionals Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, crosssectional, serological study Summary and Risk Assessment of Current Situation in the Republic of Korea and China -as of 19 Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections Middle East respiratory syndrome coronavirus in bats, Saudi Arabia Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia Middle East Respiratory Syndrome (MERS), MERS Clinical Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study Middle East respiratory syndrome (MERS) in Asia: lessons gleaned from the South Korean outbreak An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia Hospital outbreak of Middle East respiratory syndrome coronavirus Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution Middle East respiratory syndrome coronavirus infections in health care workers Middle East respiratory syndrome coronavirus (MERS-CoV) in pilgrims returning from the Hajj Update on the epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, and guidance for the public, clinicians, and public health authorities Disease outbreak news 25 October Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy